FDA approves a game-changing treatment for blood cancer

The Food and Drug Administration has approved a promising new treatment called CAR-T for a particularly deadly form of cancer.

The Food and Drug Administration on Wednesday approved a promising new treatment for a particularly deadly form of cancer, bringing hope to desperate patients while rekindling a global conversation about the escalating cost of new therapies.

The treatment, made by Gilead Sciences, is made by extracting patients’ white blood cells and re-engineering them to

You're reading a preview, sign up to read more.

More from STAT

STAT5 min readScience
In A Small Study, A Cancer Vaccine Assist Beats Immunotherapy Drugs Alone
The largest study to date of a "cancer vaccine" found that combining it with an immunotherapy drug kept patients’ tumors in check longer, on average, than the drug alone.
STAT3 min readSociety
Opinion: Compounding Pharmacies Need Stricter Federal Oversight
Compounding pharmacies are not bartenders mixing a gin and tonic. They produce essentially new drugs. The regulatory loophole that allows compounders to avoid necessary federal scrutiny must be closed.
STAT4 min read
Opinion: Opioid Overdose Should Be Treated Like Attempted Suicide: With An Emergency Hold
Having first responders provide a dose of buprenorphine after an overdose rescue is like having them provide Prozac to someone they just pulled from the ledge of a 20-story building…